Back to search

Selective cytoprotection with amifostine in concurrent radiochemotherapy for head and neck cancer

Data up to Jan 2025

Published1998
Citations182
References21

Total Citations Per Year

Abstract

References (21)

Reporting results of cancer treatment

1981 • 7,916 citations

Head and Neck Cancer

1993 • 2,263 citations

Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer.

1996 • 455 citations

Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. A meta-analysis of prospective and randomized trials.

1996 • 385 citations

Prevention of Xerostomia-Related Dental Caries in Irradiated Cancer Patients

1977 • 310 citations

Treatment of Advanced Squamous-Cell Carcinoma of the Head and Neck with Alternating Chemotherapy and Radiotherapy

1992 • 305 citations

Five-Year Update of a Randomized Trial of Alternating Radiotherapy and Chemotherapy Compared With Radiotherapy Alone in Treatment of Unresectable Squamous Cell Carcinoma of the Head and Neck

1996 • 253 citations

Overview of Combined Modality Therapies for Head and Neck Cancer

1993 • 214 citations

Head and neck cancer: chemotherapy concepts.

1988 • 181 citations

Use of radiation with or without WR-2721 in advanced rectal cancer

1992 • 134 citations

Preliminary results of a pilot study using WR-2721 before fractionated irradiation of the head and neck to reduce salivary gland dysfunction

1994 • 111 citations

Biological factors affecting the radioprotective efficiency of S-2-[3-aminopropylamino]ethylphosphorothioic acid (WR-2721): LD 50(7) doses.

1971 • 98 citations

Dental management of patients irradiated for oral cancer

1976 • 76 citations

Biological Factors Affecting the Radioprotective Efficiency of S-2-[3-Aminopropylamino] Ethylphosphorothioic Acid (WR-2721). LD 50(30) Doses

1970 • 65 citations

Radioprotection by WR-2721 against Long-Term Chronic Damage to the Rat Parotid Gland

1978 • 64 citations

Clinical study of the radioprotective effects of amifostine (YM-08310, WR-2721) on chronic radiation injury

1986 • 62 citations

Carboplatin combined with amifostine, a bone marrow protectant, in the treatment of non-small-cell lung cancer: a randomised phase II study

1995 • 55 citations

Short-Term Radioprotective Effects of WR-2721 on the Rat Parotid Glands

1978 • 52 citations

Very accelerated radiation therapy: Preliminary results in locally unresectable head and neck carcinomas

1995 • 36 citations

Split-course accelerated therapy in head and neck cancer: An analysis of toxicity

1995 • 30 citations

Intensive concomitant chemoradiotherapy in locally advanced unresectable squamous cell carcinoma of the head and neck: a phase II study of radiotherapy with cisplatin and 7-week continuous infusional fluorouracil.

1996 • 27 citations

Cited By (0)

Loading...
Selective cytoprotection with amifostine in concurrent radiochemotherapy for head and… (1998) – Annals of Oncology | Metascience Observatory Explorer